Profile - To The Moon

miyakos

Posts · 87Posts · 87
Following · 0Following · 0
Followers · 0Followers · 0

- . .
  ·2021-09-14
  Latest
  FuelCell shares Popped 30% in morning trading
  FuelCell shares Popped 30% in morning trading on topping results forecasts. FuelCell reported a rar
  FuelCell shares Popped 30% in morning trading
  388 Comment
  3
  Share
  Report
- . .
  ·2021-09-13
  Latest
  Sorry, this post has been deleted
  705 1
  2
  Share
  Report
- . .
  ·2021-09-09
  Latest
  This Robotics Growth Stock Could Turn $1,000 Into $4,000 by 2029
  Doing business as usual will be more than enough to make this company a strong investment.
  This Robotics Growth Stock Could Turn $1,000 Into $4,000 by 2029
  676 Comment
  5
  Share
  Report
- . .
  ·2021-09-08
  Latest
  Vanguard ETFs Lead as Flows Into U.S. Market Smash $600 Billion
  Previous record for full calendar year overtaken in late July. SPY assets top $400 billion as invest
  Vanguard ETFs Lead as Flows Into U.S. Market Smash $600 Billion
  498 4
  6
  Share
  Report
- . .
  ·2021-09-07
  Latest
  Hong Kong stocks close higher after strong China exports surprise
  Hang Seng index ends up 0.73%. China Enterprises index HSCE rises 1.04%. HSI property sector down 1%
  Hong Kong stocks close higher after strong China exports surprise
  535 Comment
  3
  Share
  Report
- . .
  ·2021-09-06
  Latest
  Sorry, this post has been deleted
  441 Comment
  3
  Share
  Report
- . .
  ·2021-09-05
  Latest
  Tech lifts Nasdaq to record close but Wall Street mixed on jobs report
  Dismal August jobs report calms taper fears Leisure, retail employment disappoint; cruise liners slu
  Tech lifts Nasdaq to record close but Wall Street mixed on jobs report
  593 1
  7
  Share
  Report
- . .
  ·2021-09-02
  Yeah
  Sorry, this post has been deleted
  346 Comment
  4
  Share
  Report
- . .
  ·2021-09-01
  Yes
  Merck, Ridgeback start Phase 3 trial of oral drug to prevent COVID-19
  Shares of Merck & Co. Inc. $(MRK)$ and Ridgeback Biotherapeutics said Wednesday that they have start
  Merck, Ridgeback start Phase 3 trial of oral drug to prevent COVID-19
  608 Comment
  1
  Share
  Report
- . .
  ·2021-08-31
  Latest
  Sorry, this post has been deleted
  473 Comment
  2
  Share
  Report
No following yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4088416347172780","uuid":"4088416347172780","gmtCreate":1625317032982,"gmtModify":1625317032982,"name":"miyakos","pinyin":"miyakos","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":5,"tweetSize":87,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":882081815,"gmtCreate":1631631128137,"gmtModify":1676530595572,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882081815","repostId":"1185574136","repostType":4,"repost":{"id":"1185574136","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631630152,"share":"https://ttm.financial/m/news/1185574136?lang=&edition=fundamental","pubTime":"2021-09-14 22:35","market":"us","language":"en","title":"FuelCell shares Popped 30% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1185574136","media":"Tiger Newspress","summary":"FuelCell shares Popped 30% in morning trading on topping results forecasts.\n\nFuelCell reported a rar","content":"<p>FuelCell shares Popped 30%&nbsp;in morning trading&nbsp;on&nbsp;topping results forecasts.</p>\n<p><img src=\"https://static.tigerbbs.com/d07b75f01716e7feb7fed0f8f5a9c300\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>FuelCell&nbsp;reported a rare narrower-than-expected fiscal third-quarter net loss, helped by higher gross margin, and revenue that rose above forecasts. The net loss narrowed to $12.8 million, or 4 cents a share, from $16.1 million, or 7 cents a share, in the same period a year ago. That beat the FactSet consensus for per-share losses of 5 cents, to snap a seven-quarter streak of wider-than-expected losses. Revenue rose 43.2% to $26.8 million from $18.7 million, above the FactSet consensus of $21.1 million, boosted by a $7.2 million increase in service agreements and license revenue. Gross margin improved to positive 4.1% from negative 16.7%. The stock has tumbled 49.7% year to date through Monday, while the S&amp;P 500 has gained 19.0%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FuelCell shares Popped 30% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFuelCell shares Popped 30% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-14 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FuelCell shares Popped 30%&nbsp;in morning trading&nbsp;on&nbsp;topping results forecasts.</p>\n<p><img src=\"https://static.tigerbbs.com/d07b75f01716e7feb7fed0f8f5a9c300\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>FuelCell&nbsp;reported a rare narrower-than-expected fiscal third-quarter net loss, helped by higher gross margin, and revenue that rose above forecasts. The net loss narrowed to $12.8 million, or 4 cents a share, from $16.1 million, or 7 cents a share, in the same period a year ago. That beat the FactSet consensus for per-share losses of 5 cents, to snap a seven-quarter streak of wider-than-expected losses. Revenue rose 43.2% to $26.8 million from $18.7 million, above the FactSet consensus of $21.1 million, boosted by a $7.2 million increase in service agreements and license revenue. Gross margin improved to positive 4.1% from negative 16.7%. The stock has tumbled 49.7% year to date through Monday, while the S&amp;P 500 has gained 19.0%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FCEL":"燃料电池能源"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185574136","content_text":"FuelCell shares Popped 30% in morning trading on topping results forecasts.\n\nFuelCell reported a rare narrower-than-expected fiscal third-quarter net loss, helped by higher gross margin, and revenue that rose above forecasts. The net loss narrowed to $12.8 million, or 4 cents a share, from $16.1 million, or 7 cents a share, in the same period a year ago. That beat the FactSet consensus for per-share losses of 5 cents, to snap a seven-quarter streak of wider-than-expected losses. Revenue rose 43.2% to $26.8 million from $18.7 million, above the FactSet consensus of $21.1 million, boosted by a $7.2 million increase in service agreements and license revenue. Gross margin improved to positive 4.1% from negative 16.7%. The stock has tumbled 49.7% year to date through Monday, while the S&P 500 has gained 19.0%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888750587,"gmtCreate":1631532248849,"gmtModify":1676530567447,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/888750587","repostId":"1133730816","repostType":4,"isVote":1,"tweetType":1,"viewCount":705,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883019705,"gmtCreate":1631188037807,"gmtModify":1676530490947,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/883019705","repostId":"2166312201","repostType":4,"repost":{"id":"2166312201","pubTimestamp":1631187660,"share":"https://ttm.financial/m/news/2166312201?lang=&edition=fundamental","pubTime":"2021-09-09 19:41","market":"us","language":"en","title":"This Robotics Growth Stock Could Turn $1,000 Into $4,000 by 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2166312201","media":"Motley Fool","summary":"Doing business as usual will be more than enough to make this company a strong investment.","content":"<p>Doing business as usual will be more than enough to make this company a strong investment.</p>\n<p><b>Key Points</b></p>\n<ul>\n <li>Companies with regularly recurring revenue have an easier time posting consistent revenue growth.</li>\n <li>Making products that are platforms for complex tasks is one way to build a recurring revenue base.</li>\n <li>Surgical robots are likely to be in demand in the coming years, just like they have been for the past decade.</li>\n</ul>\n<p>You've probably heard that robots are the future for everything from manufacturing to retail distribution. But have you ever considered that they might be lucrative investments in the present?</p>\n<p><b>Intuitive Surgical</b>(NASDAQ:ISRG) sits at the intersection of high-tech robotics and healthcare, and that's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the many reasons why it's an exciting growth stock. Still, with a market cap in excess of $123 billion, investors are right to be skeptical about the stock's prospects for triple-digit percentage growth. Could Intuitive Surgical be a powerhouse for your portfolio with a relatively small initial investment, or is this stock's growth story approaching stagnation? Let's investigate by taking a look at its business model to start.</p>\n<p><img src=\"https://static.tigerbbs.com/a92230e2013b2ec95bc9649c43631081\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Big growth is more than feasible</b></p>\n<p>Overall, Intuitive Surgical is primed to experience consistent and significant growth because of how it makes its income.</p>\n<p>In case you aren't familiar, its main product is the da Vinci line of robotic surgical suites, which surgeons control from a station in the operating room. It also sells maintenance contracts and an ever-increasing selection of robotic surgical tools to use in conjunction with its da Vinci units. In total, these three product categories made the company $5.16 billion in trailing revenue, 77% of which is recurring.</p>\n<p>For investors seeking growth stocks, there's nothing sweeter than a rock-solid revenue base. Importantly, there are a few different things that contribute to Intuitive's aggressive expansion of that base.</p>\n<p>The most obvious is sales of its surgical suites, but that's just the start. Once a hospital has purchased a da Vinci unit and trained its surgeons, it's safe to say that it won't be buying a similar unit from competitors.</p>\n<p>So, when Intuitive develops new surgical tools to expand the range of procedures performable with the robot, existing customers are highly likely to be interested in expanding the capabilities of the platform they own. Likewise, the more a hospital utilizes its surgical robotics, the more it'll need maintenance and a steady supply of replacement parts.</p>\n<p>All of the above means that each newly installed surgical suite will render a significant amount of revenue over its lifetime, and the company is constantly installing more with each quarter. In the second quarter of 2021, there were 10% more da Vinci systems installed globally than in Q2 of 2020. Assuming that the business will continue to deploy its products at a similar rate, it'll have a massive pool of future sales opportunities to draw from over the next decade.</p>\n<p><b>But will it make investors richer?</b></p>\n<p>I'm of the view that Intuitive's stock will multiply in value well before 2029.</p>\n<p>Over the next seven years, a $1,000 investment made today could grow to reach $4,000 in value if the stock expands with a compound annual growth rate (CAGR) of 21.9%. Let's take a closer look at why the stock is likely to grow by at least that much on an annual basis for the next few years.</p>\n<p>First, Intuitive's stock has been rising rapidly at an even faster rate over the past seven years. Since August 2014, the stock has grown by 567.5%, giving it a CAGR of about 31.5%. While skeptics might argue that the such a strong performance is unlikely to be repeated on a consistent basis, there is little evidence to suggest that growth is slowing.</p>\n<p>Even when including for the sharp drop in income and earnings that occurred when hospitals stopped performing elective surgeries during the first peak of the pandemic, the past three years have seen the company's quarterly revenue rise by nearly 59%, with quarterly earnings before interest, taxes, depreciation, and amortization (EBITDA) increasing by just over 70% in the same period. Likewise, its quarterly free cash flow (FCF) has grown by slightly more than 84% in the last five years, so its financial strength has been steadily increasing over time.</p>\n<p><img src=\"https://static.tigerbbs.com/23c1a7a479389e7ae5416faa90fb0002\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p>\n<p>ISRG Revenue (Quarterly) data by YCharts</p>\n<p>Thus, Intuitive doesn't need to change its business model or optimize its operations to keep expanding. And that means its prospects for being a winning growth stock are secure.</p>\n<p><b>When's the right time to buy?</b></p>\n<p>In my view, there's little doubt that this stock could juice a $1,000 investment today into $4,000 over the next seven years, even if growth does end up slowing slightly. Still, there remains the question of when to make a purchase.</p>\n<p>Given the company's ongoing efforts to develop new surgical tools, expand its portfolio of eligible procedures, and deploy more machines internationally, there's a smattering of catalysts for Intuitive's stock between now and 2029. At the same time, there's little chance of a competitor stealing revenue from accessory sales and maintenance for the established base of installed systems.</p>\n<p>So, there isn't much to hold investors back from buying the stock today.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Robotics Growth Stock Could Turn $1,000 Into $4,000 by 2029</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Robotics Growth Stock Could Turn $1,000 Into $4,000 by 2029\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 19:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/09/this-robotics-growth-stock-could-turn-1000-into-40/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Doing business as usual will be more than enough to make this company a strong investment.\nKey Points\n\nCompanies with regularly recurring revenue have an easier time posting consistent revenue growth....</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/09/this-robotics-growth-stock-could-turn-1000-into-40/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2021/09/09/this-robotics-growth-stock-could-turn-1000-into-40/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166312201","content_text":"Doing business as usual will be more than enough to make this company a strong investment.\nKey Points\n\nCompanies with regularly recurring revenue have an easier time posting consistent revenue growth.\nMaking products that are platforms for complex tasks is one way to build a recurring revenue base.\nSurgical robots are likely to be in demand in the coming years, just like they have been for the past decade.\n\nYou've probably heard that robots are the future for everything from manufacturing to retail distribution. But have you ever considered that they might be lucrative investments in the present?\nIntuitive Surgical(NASDAQ:ISRG) sits at the intersection of high-tech robotics and healthcare, and that's one of the many reasons why it's an exciting growth stock. Still, with a market cap in excess of $123 billion, investors are right to be skeptical about the stock's prospects for triple-digit percentage growth. Could Intuitive Surgical be a powerhouse for your portfolio with a relatively small initial investment, or is this stock's growth story approaching stagnation? Let's investigate by taking a look at its business model to start.\n\nImage source: Getty Images.\nBig growth is more than feasible\nOverall, Intuitive Surgical is primed to experience consistent and significant growth because of how it makes its income.\nIn case you aren't familiar, its main product is the da Vinci line of robotic surgical suites, which surgeons control from a station in the operating room. It also sells maintenance contracts and an ever-increasing selection of robotic surgical tools to use in conjunction with its da Vinci units. In total, these three product categories made the company $5.16 billion in trailing revenue, 77% of which is recurring.\nFor investors seeking growth stocks, there's nothing sweeter than a rock-solid revenue base. Importantly, there are a few different things that contribute to Intuitive's aggressive expansion of that base.\nThe most obvious is sales of its surgical suites, but that's just the start. Once a hospital has purchased a da Vinci unit and trained its surgeons, it's safe to say that it won't be buying a similar unit from competitors.\nSo, when Intuitive develops new surgical tools to expand the range of procedures performable with the robot, existing customers are highly likely to be interested in expanding the capabilities of the platform they own. Likewise, the more a hospital utilizes its surgical robotics, the more it'll need maintenance and a steady supply of replacement parts.\nAll of the above means that each newly installed surgical suite will render a significant amount of revenue over its lifetime, and the company is constantly installing more with each quarter. In the second quarter of 2021, there were 10% more da Vinci systems installed globally than in Q2 of 2020. Assuming that the business will continue to deploy its products at a similar rate, it'll have a massive pool of future sales opportunities to draw from over the next decade.\nBut will it make investors richer?\nI'm of the view that Intuitive's stock will multiply in value well before 2029.\nOver the next seven years, a $1,000 investment made today could grow to reach $4,000 in value if the stock expands with a compound annual growth rate (CAGR) of 21.9%. Let's take a closer look at why the stock is likely to grow by at least that much on an annual basis for the next few years.\nFirst, Intuitive's stock has been rising rapidly at an even faster rate over the past seven years. Since August 2014, the stock has grown by 567.5%, giving it a CAGR of about 31.5%. While skeptics might argue that the such a strong performance is unlikely to be repeated on a consistent basis, there is little evidence to suggest that growth is slowing.\nEven when including for the sharp drop in income and earnings that occurred when hospitals stopped performing elective surgeries during the first peak of the pandemic, the past three years have seen the company's quarterly revenue rise by nearly 59%, with quarterly earnings before interest, taxes, depreciation, and amortization (EBITDA) increasing by just over 70% in the same period. Likewise, its quarterly free cash flow (FCF) has grown by slightly more than 84% in the last five years, so its financial strength has been steadily increasing over time.\n\nISRG Revenue (Quarterly) data by YCharts\nThus, Intuitive doesn't need to change its business model or optimize its operations to keep expanding. And that means its prospects for being a winning growth stock are secure.\nWhen's the right time to buy?\nIn my view, there's little doubt that this stock could juice a $1,000 investment today into $4,000 over the next seven years, even if growth does end up slowing slightly. Still, there remains the question of when to make a purchase.\nGiven the company's ongoing efforts to develop new surgical tools, expand its portfolio of eligible procedures, and deploy more machines internationally, there's a smattering of catalysts for Intuitive's stock between now and 2029. At the same time, there's little chance of a competitor stealing revenue from accessory sales and maintenance for the established base of installed systems.\nSo, there isn't much to hold investors back from buying the stock today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":676,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889316628,"gmtCreate":1631109353464,"gmtModify":1676530470272,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/889316628","repostId":"1131499618","repostType":4,"repost":{"id":"1131499618","pubTimestamp":1631109033,"share":"https://ttm.financial/m/news/1131499618?lang=&edition=fundamental","pubTime":"2021-09-08 21:50","market":"us","language":"en","title":"Vanguard ETFs Lead as Flows Into U.S. Market Smash $600 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1131499618","media":"Bloomberg","summary":"Previous record for full calendar year overtaken in late July.\nSPY assets top $400 billion as invest","content":"<ul>\n <li>Previous record for full calendar year overtaken in late July.</li>\n <li>SPY assets top $400 billion as investors seek broad exposure.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/171bc9156c18b449edf7d973c856165b\" tg-width=\"1000\" tg-height=\"562\" width=\"100%\" height=\"auto\">Six weeks after topping a record for yearly inflows, exchange-traded funds in the U.S. have added another $100 billion.</p>\n<p>Investors have now poured $605 billion into the $6.8 trillion industry in 2021, according to data compiled by Bloomberg. The previous record for a full calendar year was $497 billion in 2020, which wasovertaken in late July.</p>\n<p><img src=\"https://static.tigerbbs.com/ca32a20513525c0a100f7ce536aeb50b\" tg-width=\"800\" tg-height=\"292\" width=\"100%\" height=\"auto\">Judging by the flows, investors have been generally keen to ride the broad market rebound from the pandemic that saw benchmark American equity gauges notch dozens of all-time-highs this year.</p>\n<p>The biggest winner is currently the Vanguard S&amp;P 500 ETF (tickerVOO) -- with $37.2 billion in new cash -- while the second place is the Vanguard Total Stock Market ETF (VTI), with $28.7 billion.</p>\n<p>The world’s largest ETF, the SPDR S&amp;P 500 ETF Trust (SPY), is nowhere near top of the leader board with just $8 billion in money added this year. But thanks to that and the rallying S&amp;P 500 index, its assets surpassed $400 billion for the first time in August.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vanguard ETFs Lead as Flows Into U.S. Market Smash $600 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVanguard ETFs Lead as Flows Into U.S. Market Smash $600 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-08 21:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-09-08/vanguard-etfs-lead-as-flows-into-u-s-market-smash-600-billion?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Previous record for full calendar year overtaken in late July.\nSPY assets top $400 billion as investors seek broad exposure.\n\nSix weeks after topping a record for yearly inflows, exchange-traded funds...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-09-08/vanguard-etfs-lead-as-flows-into-u-s-market-smash-600-billion?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/news/articles/2021-09-08/vanguard-etfs-lead-as-flows-into-u-s-market-smash-600-billion?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131499618","content_text":"Previous record for full calendar year overtaken in late July.\nSPY assets top $400 billion as investors seek broad exposure.\n\nSix weeks after topping a record for yearly inflows, exchange-traded funds in the U.S. have added another $100 billion.\nInvestors have now poured $605 billion into the $6.8 trillion industry in 2021, according to data compiled by Bloomberg. The previous record for a full calendar year was $497 billion in 2020, which wasovertaken in late July.\nJudging by the flows, investors have been generally keen to ride the broad market rebound from the pandemic that saw benchmark American equity gauges notch dozens of all-time-highs this year.\nThe biggest winner is currently the Vanguard S&P 500 ETF (tickerVOO) -- with $37.2 billion in new cash -- while the second place is the Vanguard Total Stock Market ETF (VTI), with $28.7 billion.\nThe world’s largest ETF, the SPDR S&P 500 ETF Trust (SPY), is nowhere near top of the leader board with just $8 billion in money added this year. But thanks to that and the rallying S&P 500 index, its assets surpassed $400 billion for the first time in August.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880987948,"gmtCreate":1631009921884,"gmtModify":1676530441340,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880987948","repostId":"2165330144","repostType":4,"repost":{"id":"2165330144","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1631005899,"share":"https://ttm.financial/m/news/2165330144?lang=&edition=fundamental","pubTime":"2021-09-07 17:11","market":"sh","language":"en","title":"Hong Kong stocks close higher after strong China exports surprise","url":"https://stock-news.laohu8.com/highlight/detail?id=2165330144","media":"Reuters","summary":"Hang Seng index ends up 0.73%.\nChina Enterprises index HSCE rises 1.04%.\nHSI property sector down 1%","content":"<ul>\n <li>Hang Seng index ends up 0.73%.</li>\n <li>China Enterprises index HSCE rises 1.04%.</li>\n <li>HSI property sector down 1% as Evergrande slumps.</li>\n</ul>\n<p>SHANGHAI, Sept 7 (Reuters) - Hong Kong shares rose on Tuesday after data showed China's exports unexpectedly grew at a faster pace in August, helping to take some of the pressure off the world's second-biggest economy in the midst of an uneven recovery.</p>\n<p>Exports from China rose in August at a faster-than-expected rate of 25.6% from a year earlier, up from a 19.3% gain in July, pointing to some resilience in China's industrial sector.</p>\n<p>At the close of trade, the Hang Seng index was up 190.00 points or 0.73% at 26,353.63. The Hang Seng China Enterprises index rose 1.04% to 9,468.22.</p>\n<p>The sub-index of the Hang Seng tracking energy shares&nbsp;rose 1.3%, while the IT sector rose 2.05% and the financial sector ended 0.21% higher.</p>\n<p>The top gainer on the Hang Seng was Li Ning Co Ltd, which gained 7.27%, while the biggest loser was Country Garden Holdings Co Ltd, which fell 4.06%.</p>\n<p>The property sector fell 0.98% as investor concerns over highly indebted developer <a href=\"https://laohu8.com/S/EGRNF\">China Evergrande Group</a> continued to hit the company's shares and bonds.</p>\n<p>The three biggest H-shares percentage decliners were Evergrande Property Services Group Ltd, which fell 7.96%, China Evergrande Group, which fell 7.75% and China Feihe Ltd, down 4.32%.</p>\n<p>China's main Shanghai Composite index closed up 1.51% at 3,676.59 points, while the blue-chip CSI300 index ended up 1.2%.</p>\n<p>About 1.84 billion Hang Seng index shares were traded, roughly 85% of the market's 30-day moving average of 2.17 billion shares a day. The volume traded in the previous trading session was 1.91 billion.</p>\n<p>At close, China's A-shares were trading at a premium of 40.46% over Hong Kong-listed H-shares.</p>\n<p>(Reporting by Andrew Galbraith; Editing by Shounak Dasgupta)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong stocks close higher after strong China exports surprise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong stocks close higher after strong China exports surprise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-07 17:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Hang Seng index ends up 0.73%.</li>\n <li>China Enterprises index HSCE rises 1.04%.</li>\n <li>HSI property sector down 1% as Evergrande slumps.</li>\n</ul>\n<p>SHANGHAI, Sept 7 (Reuters) - Hong Kong shares rose on Tuesday after data showed China's exports unexpectedly grew at a faster pace in August, helping to take some of the pressure off the world's second-biggest economy in the midst of an uneven recovery.</p>\n<p>Exports from China rose in August at a faster-than-expected rate of 25.6% from a year earlier, up from a 19.3% gain in July, pointing to some resilience in China's industrial sector.</p>\n<p>At the close of trade, the Hang Seng index was up 190.00 points or 0.73% at 26,353.63. The Hang Seng China Enterprises index rose 1.04% to 9,468.22.</p>\n<p>The sub-index of the Hang Seng tracking energy shares&nbsp;rose 1.3%, while the IT sector rose 2.05% and the financial sector ended 0.21% higher.</p>\n<p>The top gainer on the Hang Seng was Li Ning Co Ltd, which gained 7.27%, while the biggest loser was Country Garden Holdings Co Ltd, which fell 4.06%.</p>\n<p>The property sector fell 0.98% as investor concerns over highly indebted developer <a href=\"https://laohu8.com/S/EGRNF\">China Evergrande Group</a> continued to hit the company's shares and bonds.</p>\n<p>The three biggest H-shares percentage decliners were Evergrande Property Services Group Ltd, which fell 7.96%, China Evergrande Group, which fell 7.75% and China Feihe Ltd, down 4.32%.</p>\n<p>China's main Shanghai Composite index closed up 1.51% at 3,676.59 points, while the blue-chip CSI300 index ended up 1.2%.</p>\n<p>About 1.84 billion Hang Seng index shares were traded, roughly 85% of the market's 30-day moving average of 2.17 billion shares a day. The volume traded in the previous trading session was 1.91 billion.</p>\n<p>At close, China's A-shares were trading at a premium of 40.46% over Hong Kong-listed H-shares.</p>\n<p>(Reporting by Andrew Galbraith; Editing by Shounak Dasgupta)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165330144","content_text":"Hang Seng index ends up 0.73%.\nChina Enterprises index HSCE rises 1.04%.\nHSI property sector down 1% as Evergrande slumps.\n\nSHANGHAI, Sept 7 (Reuters) - Hong Kong shares rose on Tuesday after data showed China's exports unexpectedly grew at a faster pace in August, helping to take some of the pressure off the world's second-biggest economy in the midst of an uneven recovery.\nExports from China rose in August at a faster-than-expected rate of 25.6% from a year earlier, up from a 19.3% gain in July, pointing to some resilience in China's industrial sector.\nAt the close of trade, the Hang Seng index was up 190.00 points or 0.73% at 26,353.63. The Hang Seng China Enterprises index rose 1.04% to 9,468.22.\nThe sub-index of the Hang Seng tracking energy shares rose 1.3%, while the IT sector rose 2.05% and the financial sector ended 0.21% higher.\nThe top gainer on the Hang Seng was Li Ning Co Ltd, which gained 7.27%, while the biggest loser was Country Garden Holdings Co Ltd, which fell 4.06%.\nThe property sector fell 0.98% as investor concerns over highly indebted developer China Evergrande Group continued to hit the company's shares and bonds.\nThe three biggest H-shares percentage decliners were Evergrande Property Services Group Ltd, which fell 7.96%, China Evergrande Group, which fell 7.75% and China Feihe Ltd, down 4.32%.\nChina's main Shanghai Composite index closed up 1.51% at 3,676.59 points, while the blue-chip CSI300 index ended up 1.2%.\nAbout 1.84 billion Hang Seng index shares were traded, roughly 85% of the market's 30-day moving average of 2.17 billion shares a day. The volume traded in the previous trading session was 1.91 billion.\nAt close, China's A-shares were trading at a premium of 40.46% over Hong Kong-listed H-shares.\n(Reporting by Andrew Galbraith; Editing by Shounak Dasgupta)","news_type":1},"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":817838648,"gmtCreate":1630929051884,"gmtModify":1676530422582,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/817838648","repostId":"1121589231","repostType":4,"isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814533960,"gmtCreate":1630840174950,"gmtModify":1676530404156,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814533960","repostId":"2164803577","repostType":4,"repost":{"id":"2164803577","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630699233,"share":"https://ttm.financial/m/news/2164803577?lang=&edition=fundamental","pubTime":"2021-09-04 04:00","market":"us","language":"en","title":"Tech lifts Nasdaq to record close but Wall Street mixed on jobs report","url":"https://stock-news.laohu8.com/highlight/detail?id=2164803577","media":"Reuters","summary":"Dismal August jobs report calms taper fears\nLeisure, retail employment disappoint; cruise liners slu","content":"<ul>\n <li>Dismal August jobs report calms taper fears</li>\n <li>Leisure, retail employment disappoint; cruise liners slump</li>\n <li>Banking stocks slide, shrug off jump in bond yields</li>\n</ul>\n<p>Sept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.</p>\n<p>A majority of the 11 S&amp;P sectors ended lower, with the energy and financial indexes among those finishing in the red.</p>\n<p>Banking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.</p>\n<p>\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p>\n<p>\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"</p>\n<p>Among the biggest decliners on the S&amp;P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.</p>\n<p>The labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.</p>\n<p>On Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.</p>\n<p>Despite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&amp;P movement in the wake of a wide miss on the payrolls report.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&amp;P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite&nbsp;added 32.34 points, or 0.21%, to 15,363.52.</p>\n<p>The Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and <a href=\"https://laohu8.com/S/FB\">Facebook</a>. Tech stocks tend to perform better in a low interest-rate environment.</p>\n<p>Chinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.</p>\n<p>Biotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech lifts Nasdaq to record close but Wall Street mixed on jobs report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech lifts Nasdaq to record close but Wall Street mixed on jobs report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-04 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Dismal August jobs report calms taper fears</li>\n <li>Leisure, retail employment disappoint; cruise liners slump</li>\n <li>Banking stocks slide, shrug off jump in bond yields</li>\n</ul>\n<p>Sept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.</p>\n<p>A majority of the 11 S&amp;P sectors ended lower, with the energy and financial indexes among those finishing in the red.</p>\n<p>Banking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.</p>\n<p>\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p>\n<p>\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"</p>\n<p>Among the biggest decliners on the S&amp;P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.</p>\n<p>The labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.</p>\n<p>On Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.</p>\n<p>Despite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&amp;P movement in the wake of a wide miss on the payrolls report.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&amp;P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite&nbsp;added 32.34 points, or 0.21%, to 15,363.52.</p>\n<p>The Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and <a href=\"https://laohu8.com/S/FB\">Facebook</a>. Tech stocks tend to perform better in a low interest-rate environment.</p>\n<p>Chinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.</p>\n<p>Biotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164803577","content_text":"Dismal August jobs report calms taper fears\nLeisure, retail employment disappoint; cruise liners slump\nBanking stocks slide, shrug off jump in bond yields\n\nSept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.\nA majority of the 11 S&P sectors ended lower, with the energy and financial indexes among those finishing in the red.\nBanking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.\n\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.\n\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"\nAmong the biggest decliners on the S&P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.\nThe S&P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.\nThe labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.\nOn Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.\nDespite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&P movement in the wake of a wide miss on the payrolls report.\nUnofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite added 32.34 points, or 0.21%, to 15,363.52.\nThe Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and Facebook. Tech stocks tend to perform better in a low interest-rate environment.\nChinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.\nBiotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.\n(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812568610,"gmtCreate":1630595120830,"gmtModify":1676530352447,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812568610","repostId":"2164821842","repostType":4,"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816689882,"gmtCreate":1630495932646,"gmtModify":1676530319783,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/816689882","repostId":"2164894947","repostType":4,"repost":{"id":"2164894947","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1630493880,"share":"https://ttm.financial/m/news/2164894947?lang=&edition=fundamental","pubTime":"2021-09-01 18:58","market":"us","language":"en","title":"Merck, Ridgeback start Phase 3 trial of oral drug to prevent COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=2164894947","media":"Dow Jones","summary":"Shares of Merck & Co. Inc. $(MRK)$ and Ridgeback Biotherapeutics said Wednesday that they have start","content":"<p>Shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gained 0.4% in premarket trading. The drug makers said the study is enrolling people at least 18 years old who live in the same house as someone who tested positive for SARS-CoV-2 and had symptoms. Primary endpoints include percentage of participants with COVID-19 through day 14, the percentage of those with an adverse event and the percentage of those who had to discontinue to the study because of an adverse event. \"\"As the pandemic continues to evolve and surges are being reported in many places around the world, it is important that we investigate new ways to protect individuals exposed to the virus from becoming infected with symptomatic disease,\" said Dr. Nick Kartsonis, senior vice president, vaccines and infectious diseases, clinical research, Merck Research Laboratories. \"If successful, molnupiravir could provide an important additional option towards reducing the burden of COVID-19 on our communities.\" Merck's stock has slipped 2.2% year to date through Tuesday, while the SPDR Health Care Select Sector ETF <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has rallied 19.2% and the Dow Jones Industrial Average has advanced 15.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck, Ridgeback start Phase 3 trial of oral drug to prevent COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck, Ridgeback start Phase 3 trial of oral drug to prevent COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-09-01 18:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gained 0.4% in premarket trading. The drug makers said the study is enrolling people at least 18 years old who live in the same house as someone who tested positive for SARS-CoV-2 and had symptoms. Primary endpoints include percentage of participants with COVID-19 through day 14, the percentage of those with an adverse event and the percentage of those who had to discontinue to the study because of an adverse event. \"\"As the pandemic continues to evolve and surges are being reported in many places around the world, it is important that we investigate new ways to protect individuals exposed to the virus from becoming infected with symptomatic disease,\" said Dr. Nick Kartsonis, senior vice president, vaccines and infectious diseases, clinical research, Merck Research Laboratories. \"If successful, molnupiravir could provide an important additional option towards reducing the burden of COVID-19 on our communities.\" Merck's stock has slipped 2.2% year to date through Tuesday, while the SPDR Health Care Select Sector ETF <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has rallied 19.2% and the Dow Jones Industrial Average has advanced 15.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164894947","content_text":"Shares of Merck & Co. Inc. $(MRK)$ and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gained 0.4% in premarket trading. The drug makers said the study is enrolling people at least 18 years old who live in the same house as someone who tested positive for SARS-CoV-2 and had symptoms. Primary endpoints include percentage of participants with COVID-19 through day 14, the percentage of those with an adverse event and the percentage of those who had to discontinue to the study because of an adverse event. \"\"As the pandemic continues to evolve and surges are being reported in many places around the world, it is important that we investigate new ways to protect individuals exposed to the virus from becoming infected with symptomatic disease,\" said Dr. Nick Kartsonis, senior vice president, vaccines and infectious diseases, clinical research, Merck Research Laboratories. \"If successful, molnupiravir could provide an important additional option towards reducing the burden of COVID-19 on our communities.\" Merck's stock has slipped 2.2% year to date through Tuesday, while the SPDR Health Care Select Sector ETF $(XLV)$ has rallied 19.2% and the Dow Jones Industrial Average has advanced 15.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818206299,"gmtCreate":1630409504711,"gmtModify":1676530295144,"author":{"id":"4088416347172780","authorId":"4088416347172780","name":" . ","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088416347172780","authorIdStr":"4088416347172780"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818206299","repostId":"2163859671","repostType":4,"isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":true}